Treatment comparisons for pulmonary function and hand-grip strength
Variables . | Vitamin D3 100 000 IU/mo . | Vitamin D3 12 000 IU/mo . | P for interaction between treatment group and time . |
---|---|---|---|
Pulmonary function tests | |||
FVC, % predicted | n = 28 | n = 30 | 0.52 |
Baseline | 85.5 ± 2.8 | 90.2 ± 2.3 | |
Treatment year 1 | 85.2 ± 2.7 | 92.4 ± 2.3 | |
Treatment year 2 | 85.0 ± 2.5 | 92.1 ± 2.5 | |
FEV1, % predicted | n = 28 | n = 30 | 0.81 |
Baseline | 80.4 ± 2.4 | 84.9 ± 2.3 | |
Treatment year 1 | 79.1 ± 2.7 | 85.3 ± 2.1 | |
Treatment year 2 | 78.9 ± 2.8 | 84.5 ± 2.0 | |
FEV1/FVC ratio, % | n = 28 | n = 30 | 0.95 |
Baseline | 84.0 ± 1.5 | 83.3 ± 1.5 | |
Treatment year 1 | 82.6 ± 1.0 | 81.7 ± 1.3 | |
Treatment year 2 | 82.2 ± 1.5 | 81.6 ± 1.2 | |
FEF25-75, % predicted | n = 28 | n = 30 | 0.87 |
Baseline | 69.8 ± 5.2 | 68.8 ± 4.9 | |
Treatment year 1 | 62.9 ± 4.4 | 64.8 ± 4.3 | |
Treatment year 2 | 62.8 ± 4.4 | 65.6 ± 4.3 | |
RV/TLC ratio, % | n = 23 | n = 20 | 0.96 |
Baseline | 26.9 ± 1.3 | 25.1 ± 1.6 | |
Treatment year 1 | 25.4 ± 1.8 | 22.6 ± 1.9 | |
Treatment year 2 | 22.8 ± 1.6 | 21.8 ± 1.9 | |
DLCO, % predicted | n = 20 | n = 19 | 0.69 |
Baseline | 68.0 ± 3.2 | 72.3 ± 3.9 | |
Treatment year 1 | 62.9 ± 3.2 | 67.8 ± 2.4 | |
Treatment year 2 | 68.1 ± 3.8 | 72.9 ± 2.9 | |
FENO, ppb | n = 28 | n = 30 | 0.54 |
Baseline | 19.3 ± 2.7 | 16.9 ± 2.1 | |
Treatment year 1 | 20.5 ± 3.5 | 16.1 ± 2.1 | |
Treatment year 2 | 18.1 ± 2.7 | 16.4 ± 2.4 | |
MIP, cm H2O | n = 23 | n = 19 | 1.00 |
Baseline | 69.1 ± 5.6 | 59.9 ± 5.3 | |
Treatment year 1 | 78.7 ± 6.1 | 80.4 ± 6.3 | |
Treatment year 2 | 77.4 ± 5.0 | 74.6 ± 4.7 | |
MEP, cm H2O | n = 23 | n = 19 | 0.70 |
Baseline | 66.3 ± 3.9 | 66.3 ± 5.4 | |
Treatment year 1 | 60.4 ± 3.3 | 57.3 ± 3.1 | |
Treatment year 2 | 58.7 ± 3.4 | 56.2 ± 4.0 | |
Hand-grip strength | |||
Right hand, pounds force | n = 25 | n = 27 | 0.81 |
Baseline | 21.2 ± 3.2 | 16.9 ± 2.2 | |
Treatment year 1 | 20.6 ± 3.0 | 16.6 ± 2.4 | |
Treatment year 2 | 23.8 ± 4.1 | 17.4 ± 2.9 | |
Left hand, pounds force | n = 25 | n = 27 | 0.97 |
Baseline | 19.9 ± 3.4 | 16.0 ± 2.1 | |
Treatment year 1 | 19.0 ± 3.4 | 13.6 ± 2.4 | |
Treatment year 2 | 19.6 ± 3.6 | 15.8 ± 2.8 | |
Dominant hand, pounds force | n = 25 | n = 27 | 0.24 |
Baseline | 21.2 ± 3.2 | 17.1 ± 2.2 | |
Treatment year 1 | 20.8 ± 3.0 | 17.3 ± 2.4 | |
Treatment year 2 | 23.8 ± 4.1 | 18.1 ± 3.1 |
Variables . | Vitamin D3 100 000 IU/mo . | Vitamin D3 12 000 IU/mo . | P for interaction between treatment group and time . |
---|---|---|---|
Pulmonary function tests | |||
FVC, % predicted | n = 28 | n = 30 | 0.52 |
Baseline | 85.5 ± 2.8 | 90.2 ± 2.3 | |
Treatment year 1 | 85.2 ± 2.7 | 92.4 ± 2.3 | |
Treatment year 2 | 85.0 ± 2.5 | 92.1 ± 2.5 | |
FEV1, % predicted | n = 28 | n = 30 | 0.81 |
Baseline | 80.4 ± 2.4 | 84.9 ± 2.3 | |
Treatment year 1 | 79.1 ± 2.7 | 85.3 ± 2.1 | |
Treatment year 2 | 78.9 ± 2.8 | 84.5 ± 2.0 | |
FEV1/FVC ratio, % | n = 28 | n = 30 | 0.95 |
Baseline | 84.0 ± 1.5 | 83.3 ± 1.5 | |
Treatment year 1 | 82.6 ± 1.0 | 81.7 ± 1.3 | |
Treatment year 2 | 82.2 ± 1.5 | 81.6 ± 1.2 | |
FEF25-75, % predicted | n = 28 | n = 30 | 0.87 |
Baseline | 69.8 ± 5.2 | 68.8 ± 4.9 | |
Treatment year 1 | 62.9 ± 4.4 | 64.8 ± 4.3 | |
Treatment year 2 | 62.8 ± 4.4 | 65.6 ± 4.3 | |
RV/TLC ratio, % | n = 23 | n = 20 | 0.96 |
Baseline | 26.9 ± 1.3 | 25.1 ± 1.6 | |
Treatment year 1 | 25.4 ± 1.8 | 22.6 ± 1.9 | |
Treatment year 2 | 22.8 ± 1.6 | 21.8 ± 1.9 | |
DLCO, % predicted | n = 20 | n = 19 | 0.69 |
Baseline | 68.0 ± 3.2 | 72.3 ± 3.9 | |
Treatment year 1 | 62.9 ± 3.2 | 67.8 ± 2.4 | |
Treatment year 2 | 68.1 ± 3.8 | 72.9 ± 2.9 | |
FENO, ppb | n = 28 | n = 30 | 0.54 |
Baseline | 19.3 ± 2.7 | 16.9 ± 2.1 | |
Treatment year 1 | 20.5 ± 3.5 | 16.1 ± 2.1 | |
Treatment year 2 | 18.1 ± 2.7 | 16.4 ± 2.4 | |
MIP, cm H2O | n = 23 | n = 19 | 1.00 |
Baseline | 69.1 ± 5.6 | 59.9 ± 5.3 | |
Treatment year 1 | 78.7 ± 6.1 | 80.4 ± 6.3 | |
Treatment year 2 | 77.4 ± 5.0 | 74.6 ± 4.7 | |
MEP, cm H2O | n = 23 | n = 19 | 0.70 |
Baseline | 66.3 ± 3.9 | 66.3 ± 5.4 | |
Treatment year 1 | 60.4 ± 3.3 | 57.3 ± 3.1 | |
Treatment year 2 | 58.7 ± 3.4 | 56.2 ± 4.0 | |
Hand-grip strength | |||
Right hand, pounds force | n = 25 | n = 27 | 0.81 |
Baseline | 21.2 ± 3.2 | 16.9 ± 2.2 | |
Treatment year 1 | 20.6 ± 3.0 | 16.6 ± 2.4 | |
Treatment year 2 | 23.8 ± 4.1 | 17.4 ± 2.9 | |
Left hand, pounds force | n = 25 | n = 27 | 0.97 |
Baseline | 19.9 ± 3.4 | 16.0 ± 2.1 | |
Treatment year 1 | 19.0 ± 3.4 | 13.6 ± 2.4 | |
Treatment year 2 | 19.6 ± 3.6 | 15.8 ± 2.8 | |
Dominant hand, pounds force | n = 25 | n = 27 | 0.24 |
Baseline | 21.2 ± 3.2 | 17.1 ± 2.2 | |
Treatment year 1 | 20.8 ± 3.0 | 17.3 ± 2.4 | |
Treatment year 2 | 23.8 ± 4.1 | 18.1 ± 3.1 |
All data are mean ± SEM.